Shay Golan
@shaygo1
Followers
163
Following
330
Media
18
Statuses
220
Chair of Urology at Rabin Medical Center
Israel
Joined December 2013
Honored to welcome Prof. Yair Lotan as a visiting professor at the IUA Section of Uro-Oncology meeting. Thank you for sharing transformative research and inspiring our community. @ylotan @IUOCisrael @RMCurology @IuaIsrael
0
0
0
Our recent publication in @EurUrolOncol demonstrates - for the first time -that an AI-powered histologic biomarker (CHAI) can predict response to intravesical BCG vs. gemcitabine/docetaxel in high-grade NMIBC. A critical step forward in precision intravesical therapy.
7
33
93
Today at @RMCurology (Schneider campus) together with Dr. David Ben Meir & Dr. Nir Rahav, a Laser En Bloc RBT was performed for the 1 time in the 🌎 on a child. Many technical nuances, but all of them were successfully overcome. #teamwork. Moving forward!
0
2
5
Excited to share our real world results from 8000+ stone patients 💪5 year surgical recurrence rates for uric acid x1.5 times and for brushite and cystine more than x2.5 times than calcium oxalate 🗻 congrats to @Doc_Shpitzer David Lifshitz @Dmitry_Enikeev and whole team
1
4
3
Finally, we did it. Continue breaking the stereotypes. Present our study on laser en bloc resection for large bladder tumors following by morcellation during #EAU25. Collaboration of urology departments of @RMCurology & @MedUni_.
0
9
56
Thanks to Juan and all the co-authors for their contributions to this important study. Sure, that will give answers to most of the questions in the near future.
En Bloc Resection with Morcellation: A Game Changer for Large Bladder Tumors? 🔬 A new study explores the role of morcellation in en bloc resection of large bladder tumors, tackling challenges in specimen retrieval and pathological assessment. While traditional TURBT is widely
0
2
10
En Bloc Resection with Morcellation: A Game Changer for Large Bladder Tumors? 🔬 A new study explores the role of morcellation in en bloc resection of large bladder tumors, tackling challenges in specimen retrieval and pathological assessment. While traditional TURBT is widely
1
10
49
I refuse to share the exact details, but the Bibas children were executed by hand. Not by airstrike. BY HAND.
538
1K
8K
More data/modeling to inform the GG1/Gleason 6 relabeling debate. Projected Outcomes of Reduced-Biopsy Management of Grade Group 1 Prostate Cancer: Implications for Relabeling
academic.oup.com
AbstractBackground. Implications of relabeling Grade Group 1 prostate cancer as noncancer will depend on the recommended active surveillance strategy. Whet
0
5
26
The great event is coming. The collaboration of @IuaIsrael & section of EndoUroTechnology @Uroweb. One-day Hybrid #BPH conference with hot debates and live surgery. Don’t miss it! 📌 1 Nov 2024 📍 Rabin Medical Center, @TelAvivUni For more info ➡️ https://t.co/s9LWpyti2x
1
8
21
היה כיף להתראיין בתוכנית הרדיו ״רופא פרטי״, ברדיו צפון, על הנושא החשוב של שלפוחית שתן רגיזה. נושא חשוב שקרוב לליבי. מוזמנים להקשיב. https://t.co/nXbumb5Kuv #שלפוחיתרגיזה #אורולוגיה
1045fm.maariv.co.il
<<<< /div>
0
1
1
עמוד המידע שכתבתי על הרטבות לילה בילדים (אנורזיס) עבור קופ״ח כללית. בעיה שכיחה ומציקה, שבהחלט ניתן לטפל בה. https://t.co/uk5KT4wyWw #הרטבותלילה #פידרפואה
1
1
5
Proud to share our study. We report that age and gender exerted a significant impact on treatment costs, revealing that advanced age and female gender were both correlated with higher treatment costs in the care of ureteric stones. https://t.co/el5EcCG4TT
#endourology
link.springer.com
Urolithiasis - To assess whether age or gender affects ureteric stone management costs, in patients presenting to the Emergency Department (ED) with CT proven ureteric stones. A retrospective...
0
1
6
חברת ביומיקה מפתחת טיפול חדשני לסרטן, שמבוסס על כמה חיידקים שניתנים בקפסולות ונקרא BMC128. במחקר מקדמי, 11 חולי סרטן עם מחלה עמידה לאימונותרפיה טופלו ב-BMC128 בשילוב האימונותרפיה שלא עבדה קודם. ב-8 חולים המחלה נעצרה או נסוגה, ומעורר תקווה להמשך הדרך.
globes.co.il
הניסוי בוצע על־ידי חברת ביומיקה מקבוצת אבוג'ן הבורסאית, ובו השתתפו 11 חולים בסוגי סרטן שונים, שטופלו עד היום באימונותרפיה ללא הצלחה • בעקבות הפרסום, מניית הקבוצה עלתה ב־6.7%, והיא נסחרת כעת לפי שווי...
1
1
10
Non-randomized PrCa outcomes based on CAPRA and management/treatment strategy. Important to know......the data/findings and limitations. Release the hounds (for appropriate and inappropriate bashing of the data/conclusions)!! @dr_coops @EUplatinum
https://t.co/tZlpUYmGGC
3
10
33
Congrats @uroegg! Well deserved recognition for one of the best!
Massive congrats to 2 individuals who I love and admire more than they could ever know. @UroCancerMD and @uroegg awarded the 2024 Hugh Hampton Young and AUA Mid-Career Awards 🏆 🏆 Both so incredibly well deserving.
0
6
35
Now published in @UrolOncol by @UrologyTLVMC @HaimHerzberg @RoyManoMD et al. Natural history and health care burden of non-curative treatment for muscle-invasive bladder cancer. A fantastic bi-center collaboration with Yossi Ventua and @shaygo1 Rabin MC. https://t.co/uPXlvnftPV
1
2
5
🚨Our NEW paper out from POP-RT trial @VedangMurthy in @IJROBP !!!🤩 Elective pelvic #radiotherapy in HR-VHR #prostatecancer ⬆️ ⬆️BFFS, DFS, MFS Does toxicity REALLY increase⁉️ Short: NO Long: ~10% higher gr2 late urinary (p=NS) 1/ https://t.co/wCJud1EVGw
7
63
185